Literature DB >> 24645778

Chronic lymphocytic leukaemia: could immunological tolerance mechanisms be the origin of lymphoid neoplasms?

Ricardo García-Muñoz1, Luis Llorente.   

Abstract

Immunological tolerance theory in chronic lymphocytic leukaemia (CLL): we suggest that B cells that express B-cell receptors (BCR) that recognize their own BCR epitopes are viewed by immune system as 'dangerous cells'. BCR autonomous signalling may induce constant receptor editing and mistakes in allelic exclusion. The fact that whole BCR recognizes a self-antigen or foreing antigen may be irrelevant in early B cell development. In early B cells, autonomous signalling induced by recognition of the BCR's own epitopes simulates an antigen-antibody engagement. In the bone marrow this interaction is viewed as recognition of self-molecules and induces receptor editing. In mature B cells autonomous signalling by the BCR may promote 'reversible anergy' and also may correct self-reactivity induced by the somatic hypermutation mechanisms in mutated CLL B cells. However, in unmutated CLL B cells, BCR autonomous signalling in addition to self-antigen recognition augments B cell activation, proliferation and genomic instability. We suggest that CLL originates from a coordinated normal immunologic tolerance mechanism to destroy self-reactive B cells. Additional genetic damage induced by tolerance mechanisms may immortalize self-reactive B cells and transform them into a leukemia.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  anergy; chronic lymphocytic leukaemia; clonal selection theory; immunological tolerance; receptor editing

Mesh:

Substances:

Year:  2014        PMID: 24645778      PMCID: PMC4107664          DOI: 10.1111/imm.12285

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  152 in total

1.  Contribution of Vh gene replacement to the primary B cell repertoire.

Authors:  Zhixin Zhang; Michael Zemlin; Yui-Hsi Wang; Delicia Munfus; Leslie E Huye; Harry W Findley; S Louis Bridges; David B Roth; Peter D Burrows; Max D Cooper
Journal:  Immunity       Date:  2003-07       Impact factor: 31.745

2.  Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia.

Authors:  Davide Rossi; Silvia Rasi; Giulia Fabbri; Valeria Spina; Marco Fangazio; Francesco Forconi; Roberto Marasca; Luca Laurenti; Alessio Bruscaggin; Michaela Cerri; Sara Monti; Stefania Cresta; Rosella Famà; Lorenzo De Paoli; Pietro Bulian; Valter Gattei; Anna Guarini; Silvia Deaglio; Daniela Capello; Raul Rabadan; Laura Pasqualucci; Riccardo Dalla-Favera; Robin Foà; Gianluca Gaidano
Journal:  Blood       Date:  2011-11-10       Impact factor: 22.113

3.  IgM-producing chronic lymphocytic leukemia cells undergo immunoglobulin isotype-switching without acquiring somatic mutations.

Authors:  D G Efremov; M Ivanovski; F D Batista; G Pozzato; O R Burrone
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

Review 4.  Immunotherapy for chronic lymphocytic leukemia in the era of BTK inhibitors.

Authors:  M A Kharfan-Dabaja; W G Wierda; L J N Cooper
Journal:  Leukemia       Date:  2013-10-25       Impact factor: 11.528

5.  c-Myb is critical for B cell development and maintenance of follicular B cells.

Authors:  Matthew D Thomas; Christopher S Kremer; Kodi S Ravichandran; Klaus Rajewsky; Timothy P Bender
Journal:  Immunity       Date:  2005-09       Impact factor: 31.745

6.  Chronic lymphocytic leukemias utilizing the VH3-21 gene display highly restricted Vlambda2-14 gene use and homologous CDR3s: implicating recognition of a common antigen epitope.

Authors:  Gerard Tobin; Ulf Thunberg; Anna Johnson; Inger Eriksson; Ola Söderberg; Karin Karlsson; Mats Merup; Gunnar Juliusson; Juhani Vilpo; Gunilla Enblad; Christer Sundström; Göran Roos; Richard Rosenquist
Journal:  Blood       Date:  2003-02-13       Impact factor: 22.113

7.  Lack of the transcriptional coactivator OBF-1 prevents the development of systemic lupus erythematosus-like phenotypes in Aiolos mutant mice.

Authors:  Jian Sun; Gabriele Matthias; Michael J Mihatsch; Katia Georgopoulos; Patrick Matthias
Journal:  J Immunol       Date:  2003-02-15       Impact factor: 5.422

8.  Stereotyped patterns of somatic hypermutation in subsets of patients with chronic lymphocytic leukemia: implications for the role of antigen selection in leukemogenesis.

Authors:  Fiona Murray; Nikos Darzentas; Anastasia Hadzidimitriou; Gerard Tobin; Myriam Boudjogra; Cristina Scielzo; Nikolaos Laoutaris; Karin Karlsson; Fanny Baran-Marzsak; Athanasios Tsaftaris; Carol Moreno; Achilles Anagnostopoulos; Federico Caligaris-Cappio; Dominique Vaur; Christos Ouzounis; Chrysoula Belessi; Paolo Ghia; Fred Davi; Richard Rosenquist; Kostas Stamatopoulos
Journal:  Blood       Date:  2007-10-24       Impact factor: 22.113

Review 9.  Potential roles of activation-induced cytidine deaminase in promotion or prevention of autoimmunity in humans.

Authors:  Anne Durandy; Tineke Cantaert; Sven Kracker; Eric Meffre
Journal:  Autoimmunity       Date:  2013-01-10       Impact factor: 2.815

10.  Chronic lymphocytic leukemia B cells expressing AID display dissociation between class switch recombination and somatic hypermutation.

Authors:  Pablo Oppezzo; Françoise Vuillier; Yuri Vasconcelos; Gérard Dumas; Christian Magnac; Beatrice Payelle-Brogard; Otto Pritsch; Guillaume Dighiero
Journal:  Blood       Date:  2003-01-09       Impact factor: 22.113

View more
  4 in total

1.  Follicular lymphoma: in vitro effects of combining lymphokine-activated killer (LAK) cell-induced cytotoxicity and rituximab- and obinutuzumab-dependent cellular cytotoxicity (ADCC) activity.

Authors:  Ricardo García-Muñoz; Ascensión López-Díaz-de-Cerio; Jesus Feliu; Angel Panizo; Pilar Giraldo; Mercedes Rodríguez-Calvillo; Carlos Grande; Esther Pena; Mayte Olave; Carlos Panizo; Susana Inogés
Journal:  Immunol Res       Date:  2016-04       Impact factor: 2.829

2.  High somatic mutation and neoantigen burden are correlated with decreased progression-free survival in multiple myeloma.

Authors:  A Miller; Y Asmann; L Cattaneo; E Braggio; J Keats; D Auclair; S Lonial; S J Russell; A K Stewart
Journal:  Blood Cancer J       Date:  2017-09-22       Impact factor: 11.037

3.  High resolution IgH repertoire analysis reveals fetal liver as the likely origin of life-long, innate B lymphopoiesis in humans.

Authors:  Anindita Roy; Vojtech Bystry; Georg Bohn; Katerina Goudevenou; Tomas Reigl; Maria Papaioannou; Adam Krejci; Sorcha O'Byrne; Aristeidis Chaidos; Andrea Grioni; Nikos Darzentas; Irene A G Roberts; Anastasios Karadimitris
Journal:  Clin Immunol       Date:  2017-06-20       Impact factor: 3.969

4.  BCR and chemokine responses upon anti-IgM and anti-IgD stimulation in chronic lymphocytic leukaemia.

Authors:  Andrea Haerzschel; Julie Catusse; Evelyn Hutterer; Manuela Paunovic; Katja Zirlik; Hermann Eibel; Peter W Krenn; Tanja N Hartmann; Meike Burger
Journal:  Ann Hematol       Date:  2016-08-20       Impact factor: 3.673

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.